(Press-News.org) Boston - Kevin Haigis, PhD, Chief Scientific Officer, Dana-Farber Cancer Institute, has been named Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is a distinguished lifetime honor bestowed upon AAAS members by their peers.
Haigis is recognized within Biological Sciences for his distinguished contributions to understanding the complex diversity of cellular dysregulation by different variants of RAS mutations and their consequences in pathophysiology and treatment.
Haigis has been a member of the Harvard Medical School faculty since 2007, currently as a Professor of Medicine. The Haigis laboratory combines computational and informatic approaches with experimental approaches in models to study the relationship between RAS signaling, colorectal cancer, and inflammation.
Haigis received his PhD from the University of Wisconsin in 2002 and continued training as a postdoctoral fellow in the laboratory of Tyler Jacks at MIT. He previously served as Director of Cancer Genetics at Beth Israel Deaconess Cancer before joining Dana-Farber. He is also an Associate Member of the Broad Institute of MIT and Harvard.
This year Haigis is among 502 scientists, engineers, and innovators elected across 24 AAAS disciplinary sections, as AAAS celebrates the 150th anniversary of the AAAS Fellows.
The tradition of AAAS Fellows began in 1874. This year’s AAAS Fellows will be celebrated at the annual Fellows Forum in Washington, D.C. on September 21, 2024.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Dana-Farber is a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School.
We provide the latest treatments in cancer for adults through Dana-Farber Brigham Cancer Center and for children through Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dana-Farber is the only hospital nationwide with a top 5 U.S. News & World Report Best Cancer Hospital ranking in both adult and pediatric care.
END
Dana-Farber Chief Scientific Officer, Kevin Haigis, PhD, elected as Fellow of the American Association for the Advancement of Science
2024-04-18
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Siblings with unique genetic change help scientists progress drug search for type 1 diabetes
2024-04-18
Two siblings who have the only known mutations in a key gene anywhere in the world have helped scientists gain new insights that could help progress the search for new treatments in type 1 diabetes.
Type 1 diabetes (also known as autoimmune diabetes) is a devastating and life-long disease, in which the patient’s immune cells wrongly destroy the insulin producing beta cells in the pancreas. People living with autoimmune diabetes need to test their blood sugar and inject insulin throughout their lives to control their blood sugars and prevent complications.
Autoimmune ...
Four MD Anderson researchers elected AAAS Fellows
2024-04-18
HOUSTON ― In recognition of their significant achievements in the realm of cancer care and research, four researchers at The University of Texas MD Anderson Cancer Center have been elected fellows of the American Association for the Advancement of Science (AAAS). This prestigious distinction stands as one of the highest accolades within the scientific research community.
Boyi Gan, Ph.D., Candelaria Gomez-Manzano, M.D., Li Ma, Ph.D., and Sattva Neelapu, M.D., now join this esteemed group of fellows elected by their peers. AAAS’s annual tradition of recognizing leading scientists as fellows dates to 1874. With these newest additions, 68 MD Anderson faculty members ...
Computational biology pioneer Katie Pollard elected as AAAS fellow
2024-04-18
SAN FRANCISCO—April 18, 2024—The American Association for the Advancement of Science (AAAS), one of the world’s largest general scientific societies, has elected Gladstone Senior Investigator Katie Pollard, PhD, into its new class of AAAS Fellows, a lifetime honor within the scientific community.
AAAS recognized Pollard for her “distinguished contributions to the field of computational biology and bioinformatics, particularly her discovery of Human Accelerated Regions, and development of ...
New “window-of-opportunity” clinical trials explore cutting-edge treatments for cancers of the liver, head and neck
2024-04-18
April 18, 2024, TORONTO – A new round of clinical trials supported by the Ontario Institute for Cancer Research (OICR) will harness a unique opportunity to test some of the newest treatment strategies for a range of different cancers.
OICR has announced two new clinical trials as part of its Window-of-Opportunity (WOO) Network, which brings together Ontario researchers, clinicians and patients to study the biology of newly diagnosed and recurrent tumours.
“‘Window-of-opportunity’ clinical trials take advantage of the two-to-eight-week period between the diagnosis of cancer and the surgery to remove the cancer, at ...
Can bismuth prevent oil leaks – (and save Norwegians billions)?
2024-04-18
Over the next 25 years, as the world shifts away from fossil fuels, the oil and gas wells that have sustained the fossil fuel age will have to be plugged.
No big deal, you might think, drilling those wells was the hard part. Plugging them should be no problem. But think again.
The Norwegian Continental Shelf, as an example, is punctured by more than 2000 wells. Harald Linga, centre director for SWIPA (see box), a Centre for Research Based Innovation based at SINTEF, Scandinavia’s largest independent research institute, estimates that plugging them using today’s technology will cost upwards of NOK 800 billion – that’s USD 73 billion.
And while oil ...
Atmospheric isotopes reveal 4.5 billion years of volcanism on Jupiter’s moon Io
2024-04-18
Sulfur and chlorine isotopes in the atmosphere of Jupiter’s moon Io indicate that it has been volcanically active for the entire 4.57 billion-year history of the Solar System, according to a new study. The findings offer new insights into the moon’s history. Io is the most volcanically active body in the Solar System. This extreme level of volcanic activity is the result of tidal heating from friction generated within the moon’s interior as it is pulled between Jupiter and its neighboring moons of Europa and Ganymede. However, how long Io has hosted such extensive ...
An ink for 3D-printing flexible devices without mechanical joints
2024-04-18
For engineers working on soft robotics or wearable devices, keeping things light is a constant challenge: heavier materials require more energy to move around, and – in the case of wearables or prostheses – cause discomfort. Elastomers are synthetic polymers that can be manufactured with a range of mechanical properties, from stiff to stretchy, making them a popular material for such applications. But manufacturing elastomers that can be shaped into complex 3D structures that go from rigid to rubbery has been unfeasible until now.
“Elastomers are usually cast so that their composition cannot be changed in all three dimensions over short length scales. To overcome ...
Association for Chemoreception Sciences (AChemS) 46th Annual Meeting
2024-04-18
Media Contact:
Dr. Alissa Nolden, Chair - Public Information & Affairs Committee, anolden@umass.edu
Bonita Springs, FL— The Association for Chemoreception Sciences (AChemS) stands as a premier organization dedicated to advancing the understanding of chemosensory systems. With a rich history spanning over four decades, AChemS has played a pivotal role in fostering interdisciplinary research and collaboration in the fields of taste, smell, and chemical senses. AChemS provides a platform for scientists, clinicians, and industry members from diverse backgrounds to exchange ideas, present cutting-edge research findings, and address pressing challenges ...
How the Birmingham Drug Discovery Hub created an investment-ready ‘drug library’
2024-04-18
A novel approach to drug discovery is enabling University of Birmingham researchers to overcome the ‘valley of death’, where projects fail due to the funding gap between original research and commercial investment.
The approach, detailed in a feature published in the April issue of Drug Discovery Today, has attracted more than £4m in industry funding, grants and industry awards, on the back of just £0.2m investment from the University’s Dynamic Investment Fund (DIF).
The Birmingham Drug Discovery Hub ...
Scientists uncover 95 regions of the genome linked to PTSD
2024-04-18
In posttraumatic stress disorder (PTSD), intrusive thoughts, changes in mood, and other symptoms after exposure to trauma can greatly impact a person’s quality of life. About 6 percent of people who experience trauma develop the disorder, but scientists don’t yet understand the neurobiology underlying PTSD.
Now, a new genetic study of more than 1.2 million people has pinpointed 95 loci, or locations in the genome, that are associated with risk of developing PTSD, including 80 that had not been previously identified. The study, from the PTSD working group within the Psychiatric Genomics Consortium (PGC - PTSD) together with Cohen ...